CSS LLC/IL - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$233,000
-18.8%
55,200
-46.3%
0.01%0.0%
Q2 2022$287,000
+32.3%
102,700
+171.7%
0.01%
+37.5%
Q1 2022$217,000
-20.8%
37,800
+26.0%
0.01%
-20.0%
Q4 2021$274,000
-48.8%
30,000
-40.0%
0.01%
-56.5%
Q3 2021$535,000
+14.8%
50,000
+66.7%
0.02%
+21.1%
Q2 2021$466,000
-70.5%
30,000
-69.2%
0.02%
-70.8%
Q1 2021$1,578,000
+544.1%
97,343
+486.4%
0.06%
+364.3%
Q2 2020$245,00016,6000.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders